BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 10849757)

  • 1. Functions of cathepsin K in bone resorption. Lessons from cathepsin K deficient mice.
    Saftig P; Hunziker E; Everts V; Jones S; Boyde A; Wehmeyer O; Suter A; von Figura K
    Adv Exp Med Biol; 2000; 477():293-303. PubMed ID: 10849757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice.
    Saftig P; Hunziker E; Wehmeyer O; Jones S; Boyde A; Rommerskirch W; Moritz JD; Schu P; von Figura K
    Proc Natl Acad Sci U S A; 1998 Nov; 95(23):13453-8. PubMed ID: 9811821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cathepsin K knockout mice develop osteopetrosis due to a deficit in matrix degradation but not demineralization.
    Gowen M; Lazner F; Dodds R; Kapadia R; Feild J; Tavaria M; Bertoncello I; Drake F; Zavarselk S; Tellis I; Hertzog P; Debouck C; Kola I
    J Bone Miner Res; 1999 Oct; 14(10):1654-63. PubMed ID: 10491212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio.
    Kiviranta R; Morko J; Alatalo SL; NicAmhlaoibh R; Risteli J; Laitala-Leinonen T; Vuorio E
    Bone; 2005 Jan; 36(1):159-72. PubMed ID: 15664014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linking osteopetrosis and pycnodysostosis: regulation of cathepsin K expression by the microphthalmia transcription factor family.
    Motyckova G; Weilbaecher KN; Horstmann M; Rieman DJ; Fisher DZ; Fisher DE
    Proc Natl Acad Sci U S A; 2001 May; 98(10):5798-803. PubMed ID: 11331755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cathepsin K deficiency partially inhibits, but does not prevent, bone destruction in human tumor necrosis factor-transgenic mice.
    Schurigt U; Hummel KM; Petrow PK; Gajda M; Stöckigt R; Middel P; Zwerina J; Janik T; Bernhardt R; Schüler S; Scharnweber D; Beckmann F; Saftig P; Kollias G; Schett G; Wiederanders B; Bräuer R
    Arthritis Rheum; 2008 Feb; 58(2):422-34. PubMed ID: 18240253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pycnodysostosis: role and regulation of cathepsin K in osteoclast function and human disease.
    Motyckova G; Fisher DE
    Curr Mol Med; 2002 Aug; 2(5):407-21. PubMed ID: 12125807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoclastic bone degradation and the role of different cysteine proteinases and matrix metalloproteinases: differences between calvaria and long bone.
    Everts V; Korper W; Hoeben KA; Jansen ID; Bromme D; Cleutjens KB; Heeneman S; Peters C; Reinheckel T; Saftig P; Beertsen W
    J Bone Miner Res; 2006 Sep; 21(9):1399-408. PubMed ID: 16939398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of cathepsin K in normal bone resorption.
    Troen BR
    Drug News Perspect; 2004; 17(1):19-28. PubMed ID: 14993931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel pycnodysostosis mouse model uncovers cathepsin K function as a potential regulator of osteoclast apoptosis and senescence.
    Chen W; Yang S; Abe Y; Li M; Wang Y; Shao J; Li E; Li YP
    Hum Mol Genet; 2007 Feb; 16(4):410-23. PubMed ID: 17210673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mice lacking cathepsin K maintain bone remodeling but develop bone fragility despite high bone mass.
    Li CY; Jepsen KJ; Majeska RJ; Zhang J; Ni R; Gelb BD; Schaffler MB
    J Bone Miner Res; 2006 Jun; 21(6):865-75. PubMed ID: 16753017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erosive arthritis in a patient with pycnodysostosis: an experiment of nature.
    Ainola M; Valleala H; Nykänen P; Risteli J; Hanemaaijer R; Konttinen YT
    Arthritis Rheum; 2008 Nov; 58(11):3394-401. PubMed ID: 18975331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased Bone Resorption during Lactation in Pycnodysostosis.
    Jansen IDC; Papapoulos SE; Bravenboer N; de Vries TJ; Appelman-Dijkstra NM
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific biological functions of vacuolar-type H(+)-ATPase and lysosomal cysteine proteinase, cathepsin K, in osteoclasts.
    Sahara T; Itoh K; Debari K; Sasaki T
    Anat Rec A Discov Mol Cell Evol Biol; 2003 Feb; 270(2):152-61. PubMed ID: 12524690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cathepsins in the osteoclast.
    Goto T; Yamaza T; Tanaka T
    J Electron Microsc (Tokyo); 2003; 52(6):551-8. PubMed ID: 14756243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency.
    Gelb BD; Shi GP; Chapman HA; Desnick RJ
    Science; 1996 Aug; 273(5279):1236-8. PubMed ID: 8703060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The regulation of bone resorption in tooth formation and eruption processes in mouse alveolar crest devoid of cathepsin k.
    Okaji M; Sakai H; Sakai E; Shibata M; Hashimoto F; Kobayashi Y; Yoshida N; Okamoto K; Yamamoto K; Kato Y
    J Pharmacol Sci; 2003 Apr; 91(4):285-94. PubMed ID: 12719657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent and selective inhibition of human cathepsin K leads to inhibition of bone resorption in vivo in a nonhuman primate.
    Stroup GB; Lark MW; Veber DF; Bhattacharyya A; Blake S; Dare LC; Erhard KF; Hoffman SJ; James IE; Marquis RW; Ru Y; Vasko-Moser JA; Smith BR; Tomaszek T; Gowen M
    J Bone Miner Res; 2001 Oct; 16(10):1739-46. PubMed ID: 11585335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cathepsin K and the design of inhibitors of cathepsin K.
    Yamashita DS; Dodds RA
    Curr Pharm Des; 2000 Jan; 6(1):1-24. PubMed ID: 10637370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The regulation of cathepsin K gene expression.
    Troen BR
    Ann N Y Acad Sci; 2006 Apr; 1068():165-72. PubMed ID: 16831915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.